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ABSTRACT  
  
Background  
The objective of this open cohort study was to assess the association between  
neurologic complications in patients with definite native-valve infective endocarditis (IE) and 
cerebral microembolism (MES). MES detection was performed with one-hour, bilateral 
middle cerebral arteries (MCA) insonation using a Transcranial Doppler ultrasound (TCD) 
machine. 
 
Methods and results 
Thirty patients with definite native-valve IE were stratified into two groups based upon the 
presence of MES. The most striking difference between the two groups of patients was the 
incidence of clinically evident neurologic complications. Neurologic complications of IE 
occurred in ten (83.3%) patients with positive MES and in six (33.3%) MES-negative patients 
(p=0.021). Ischemic stroke was the most common complication, occurring in eleven of 
sixteen patients, followed by meningitis in four patients and cerebritis in one patient.  
There was a trend towards greater in-hospital mortality in patients with recorded MES than 
MES negative, although this was not statistically significant (33.3% vs 16.6%; p=0.392).  
 
Conclusions 
Our results reveal a significant association between MES and neurologic complications in 
patients with native-valve infective endocarditis. TCD is a promising tool in predicting 
individual patient risk for neurological complications of IE. 
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BACKGROUND  
 Neurologic complications can occur in 21% to 56% of  patients with infective 
endocarditis  (IE) (1-6). Cerebral emboli, occurring in 42-62% of all these patients, can be 
particularly devastating.  Early detection of a clinically benign variant known as cerebral 
microembolism may offer assistance in identifying a need for early cardiac surgery thus 
improving morbidity and mortality.  They are also an indicator of an increased risk of stroke 
(7). Transcranial Doppler ultrasound (TCD) is a useful tool for the detection of microembolic 
material, both gaseous and solid, within intracranial cerebral arteries. Cerebral microemboli 
are recorded in up to 43% of patients with IE using TCD (7-9).   
The most effective methods to prevent  neurological complications and their severe 
consequences are early diagnosis and appropriate therapy of IE (1,3,10,11). Clinical studies 
demonstrate that early treatment significantly decreases the rate of embolic events 
(11,12,13).  
The literature regarding cerebral microembolism and patients with IE is sparse. Prior studies 
often included small patient populations, limited data, short recording times, and one 
insonated MCA (8,9). One trial demonstrated that the sensitivity and specificity of 
microembolic signal (MES) recordings detection method in patients with potential cardiac 
sources of embolism (one artery insonation during 30 minutes recording) was 31% and 95% 
respectively (9). 
The aim of this study was to assess the association between neurologic 
complications in patients with definite native-valve left-sided IE and cerebral microembolism 
detected by TCD using two 2-MHz probes and 60 minute recording time.   
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METHODS 
Data collection 
This prospective study was performed between January 2003 and December 2007 at 
the University Hospital for Infectious Diseases in Zagreb. The following parameters were 
recorded in a database: age, gender, physical and neurological signs, clinical outcome, 
echocardiography findings [transthoracic (TTE) and transesophageal (TEE) respectively], 
brain CT scan, antibiotic regimen, blood cultures, autopsy findings and microembolic signal 
(MES) recordings. Data was collected during the first 72 hours after admission to the 
hospital. Brain CT scans were performed on patients who developed neurologic 
complications.  
 
Patients’ selection 
Adult (≥18 years) patients with a diagnosis of native-valve IE according to modified 
Duke’s criteria were considered for TCD. Patients were excluded from the study if they had 
right-sided IE, prosthetic heart valve(s), other possible origin(s) of cerebral microembolism, 
temporal bone ‘acoustic window’ absence, or if treated with parenteral antibiotics for more 
than two weeks prior to TCD. Other possible etiologies of MES include: aortic arch 
atheroma, atrial fibrillation, atrial myxoma, dilated cardiomyopathy, left ventricular thrombus, 
mitral valve prolapse, mitral valve calcification and carotid artery plaques. MES recording in 
the prosthetic valve IE (PVIE) group was not valid as a predictive tool. These findings were 
previously found to be not specific (14). Patients were excluded if they demonstrated any 
neurological symptoms prior to the initiation of the study.  
 
Definitions 
Definite infective  endocarditis was diagnosed according to modified Duke’s criteria 
(15). The neurologic complications were divided into infectious (meningitis and brain 
abscess/cerebritis) and non-infectious (ischemic stroke and cerebral hemorrhage) 
complications. An ischemic stroke was diagnosed by the presence of a focal neurological 
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deficit that persisted over 24 hours in conjunction with a positive finding on the CT or MRI 
image.  Cerebral hemorrhage was defined as intracranial bleeding in the setting of acute 
neurological change and a positive CT scan finding. The diagnosis of bacterial meningitis 
required neutrophilic pleocytosis ( 100 white cells/ml of CSF with more than 50% 
neutrophils), CSF-blood glucose ratio 0,4 and CSF protein concentration >0.450 g/l. The 
diagnosis of a brain abscess/cerebritis required radiologic features. Neurologic complications 
that occurred at any point during the disease course were considered associated with IE. 
According to the presence of microembolic signals (MES) the patients were stratified into 
’MES positive’ and ‘MES negative’ group. MES positive was defined as ≥ 1 microembolic 
signal within a one-hour record. 
 
Transcranial Doppler ultrasound  
TCD monitoring was performed by using a Multidop 4 X (DWL, Sipplingen, Germany) 
with two 2-MHz probes of 1.7 cm in diameter. The software used was TCD-8 for MDX, 
version 8.0 by Aaslid Rune.  
The scale was set between 32-100 and +150 cm/s. The machine employed a 128-
point fast Fourier transform (FFT) resolution, FFT length of 2 ms and FFT overlap of 60%. 
The high-pass filter was set at 100 Hz, detection threshold at 9 dB and the power was set at 
70%. A sample volume of 5 mm in length and a low gain provided settings optimal for 
embolus discrimination from the background spectrum. 
Both middle cerebral arteries (MCA) were insonated simultaneously through the 
temporal bone windows at a depth of 48-58 mm, according to standard criteria, for a period 
of 60 minutes (7,16). The probes were secured on the head of the patient with a specially 
designed spectacle frame, which assurred a constant angle of insonation. All MES were 
automatically recorded on a hard disk and later analyzed off-line by a manual operator. The 
following criteria were required in order to demonstrate MES: random occurrence, brief 
duration (0.1 second), high intensity (minimum 9 dB above background intensity), primary 
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unidirectional quality within the spectrum, and causing a spike in the power/intensity trace 
accompanied by an audible “chirp” or “pop”.  
 
Statistical analysis 
Univariate statistics included calculation of the mean values, standard deviations, 
median and interquartiles for continuous variables and frequencies for the categorical 
variables. Bivariate statistics assessed the differences between ‘MES positive’ and ‘MES 
negative’ groups. The Mann-Whitney test was used to estimate the difference amongst 
continuous variables. For categorical data, the chi-square and Fisher’s exact test were used. 
Data were analyzed using the ‘SAS 9.1’ software (SAS Institute Inc., Cary, NC). 
 
RESULTS 
102 patients with endocarditis were treated in our hospital during the 5-year period. 
TCD was successfully performed in thirty patients. Seventy-two patients were excluded from 
the study due to prosthetic-valve IE (16 patients), other known or possible origin of cerebral 
microembolism (13 patients), those with right-sided IE (14 patients), patients with prior 
history of parenteral antibiotic treatment more than two weeks before TCD (22 patients), 
patients without temporal bone ‘acoustic window’ (5 patients) and two patients who died of 
reasons not associated with infective endocarditis (hepatorenal syndrome and disseminated 
breast carcinoma, respectively). Thirty patients remained in the study to test the association 
between cerebral microembolism and neurologic complications. The basic cerebral 
hemodynamic parameters (mean blood flow velocities and pulsatility indexes) in all 
participating patients were within normal range. There were no patients with coagulopathies. 
Baseline demographic data and characteristics of the patients with and without 
recorded MES are presented in Table 1. Microembolic signals were recorded in twelve of 
thirty patients with left-sided IE. The two groups did not differ in age or gender. Although 
there were more patients with an affected mitral valve in the MES-positive group (58.3% vs 
33.3%), the difference was not statistically significant (p=0.328). Staphylococcal infections 
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were more common in patients with recorded MES, however there was no statistical 
difference. This is likely secondary to the small patient population (58.3% vs 27.7%, 
difference 31%, 95%CI 0 to 58%).  
The sensitivity and specificity of the method was 83.3% and 85.7% respectively. 
Positive predictive value was 83.3% and the relative risk for neurological complication in 
MES positive patients was 2.50.  
The most striking difference between the two groups of patients was the incidence of 
clinical neurologic complications. Neurologic complications of IE occurred in ten (83.3%) 
patients with positive MES and in six (33.3%) MES-negative patients (p=0.021). The most 
common non-infectious morbidity was ischemic stroke. It occurred in eleven of sixteen 
patients (68.7%). Infectious complications occurred in five of sixteen patients (31.2%) 
(bacterial meningitis in four patients and cerebritis in one patient).  
Staphylococcus aureus was the most common pathogen in patients with meningitis (three 
patients). Moraxella lacunata cerebritis was found in one patient with endocarditis. 
 The incidence of neurologic complications that developed after the start of 
antimicrobial treatment was 53.3% (16/30). The duration of treatment before the onset of 
symptoms ranged between 3-23 days (Table 2). In 68.7% (11/16) of these patients, the 
treatment course lasted ≤ 8 days. The etiology was secondary to staphylococcal infection in 
50% of the patients and mitral valve lesions in 62.5% of patients. 
 Twelve patients with staphylococcal IE were included in study. Seven of these 
patients were MES positive and five patients were MES negative. In the MES positive group 
all patients developed neurological complications (7/7) compared with only one patient in the 
MES negative group (1/5; 20%). 
 Four patients in the MES positive group of staphylococcal IE were found to have 
large and mobile vegetations attached to the anterior mitral leaflet. One patient had 
involvement of the posterior mitral leaflet. The aortic valves were affected in two patients 
with vegetations. These measured 8×4 mm and 12x9 mm in size. The latter vegetation was 
found at the bicuspid valve accompanied by a paravalvular abscess that was 22×24 mm in 
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size. In the MES negative group of staphylococcal IE, the single patient who developed 
neurologic complications had an anterior mitral leaflet vegetation 12×3 mm in size. The 
echocardiography in the remaining patients revealed smaller or wide-base vegetations. 
A proportion of the patients were misclassified, particularly in non-staphylococcal IE group. 
Neurological complications developed in 60% (3/5) of the MES positive and in 38.4% 
(5/13) of the MES negative, non-staphylococcal IE. This difference was less prominent in the 
affected valves: 87.5% (7/8) of the MES positive patients with mitral valve IE had a 
neurologic event compared with 75% (3/4) of the MES positive patients with non-mitral IE. 
Furthermore, MES negative groups with neurologic complications showed similar injury of 
the mitral valve (37.5% vs 30%).  
 Five patients underwent valvular surgery due to severe aortic (three patients) and 
mitral (two patients) regurgitation. One of these patients was MES positive (mitral valve IE) 
and four patients were MES negative. Ischemic stroke developed in two patients prior to 
surgery, one of whom was MES positive and another who was MES negative. 
There were seven patients in MES positive group without indications for surgery 
(7/12; 58.3%). Six of these patients developed neurological complication (85.7%). The most 
common complication was meningitis (four patients) followed by cerebritis (one patient), and 
finally ischemic stroke (one patient). 
Systemic embolizations were also more common among MES-positive patients 
(58.3% vs 16.6%; p=0.045). There was a trend towards greater in-hospital mortality in 
patients with recorded MES than MES negative, although this was not statistically significant 
(33.3% vs 16.6%; p=0.392). Five of sixteen patients with neurologic complications died 
compared to two out of fourteen patients without. 
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DISCUSSION 
We found that the patients with native-valve IE with at least one MES detected by 
TCD are at greater risk for symptomatic neurologic complications. The combined use of  
both MCA insonation and extended time of MES recording increased the sensitivity of the 
method from 31% to 83.3% (9). 
MES were found in 40% of the patients. Over 80% of these patients manifested 
neurologic complications. This was more common in comparison to patients with neurologic 
complications without recorded MES. The co-existence of MES and neurologic 
complications was commonly seen with mitral valve endocarditis and staphylococcal 
infections. This is similar to previous reports (7,11,12). Furthermore, the co-existence of 
cerebral and systemic embolization was also evident.  
The high incidence of neurologic morbidity  (53.3%) despite ongoing antimicrobial 
treatment is likely the result of short treatment duration, staphylococcal infection and 
frequent vegetations on mitral valve.  
 Our study has several limitations. One limitation is the small patient population, which 
resulted from the rigid exclusion criteria used to enhance the specificity of the study . This 
was done to assure the origin of emboli. The strict exclusion criteria may also result in 
selection bias. Due to the highly selective approach, the number of potential confounding 
variables was minimized making our results more reliable. The sensitivity and specificity of 
our method were both high, particularly in regards to infectious complications. Unfortunately, 
the method failed to predict an embolic stroke in a proportion of patients. A repeat 
examination would likely be beneficial by increasing the sensitivity of this method. Due to the 
small sample size and subsequent lack of statistical significance, we were unable to show 
that microembolizations are associated with greater mortality of IE despite the obvious trend 
toward poorer outcome.  
Our results reveal a significant association between MES and neurological 
complications in patients with definite native-valve infective endocarditis. It appears that TCD 
is a promising tool for predicting individual patient risk for neurologic complications.  
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Larger studies are necessary to validate our findings. These studies will need to 
evaluate the combination MES with current risk characteristics of infective endocarditis to 
determine how MES can improve the predictive accuracy of existing risk stratification. 
Further studies should focus on the patients who do not have other indications for valvular 
surgery.  
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Table 1.    Baseline demographic data and characteristics of thirty patients with definite  
native-valve infective endocarditis 
 
 
all patients 
 
n=30 
MES*-positive 
group 
n=12 
MES-negative 
group 
n=18 
 
p  
age (years)       
            mean±SD 
            median (interquartiles)    
 
54,5±17,6 
58 (43 - 69) 
 
53,8±19,8 
61,5 (38 - 68) 
 
54,9±16,6 
58 (43 - 69) 
 
0,932 
 
gender 
                   male 
                   female 
 
17 (56,6%) 
13 (43,3%) 
 
5 (41,6%) 
7 (58,3%) 
 
12 (66,6%) 
6 (33,3%) 
 
0,328 
     
affected heart valve 
                   aortic 
                   mitral 
                   both valve 
 
14 (46,6%) 
13 (43,3%) 
3 (10%) 
 
4 (33,3%) 
7 (58,3%) 
1 (8,3%) 
 
10 (55,5%) 
6 (33,3 %) 
2 (11,1%) 
 
0,411 
0,328 
N/A 
     
etiology     
S. aureus 
MRSA 
Str. bovis 
Str. intermedius 
Str. viridans 
Str. agalactiae 
Group C Streptococcus 
10 
2 
1 
1 
2 
2 
1 
5 
2 
0 
1 
0 
2 
1 
5 
0 
1 
0 
2 
0 
0 
 
 
 
 
N/A 
Enterococcus faecalis 3 0 3  
Moraxella lacunata 1 0 1  
H. parainfluenzae 1 1 0  
Coxiella burnetti 1 0 1  
negative blood cultures/serology 5 0 5  
     
neurological complications  
     non-infectious complications 
              ischemic stroke 
              cerebral haemorrhage 
     infectious complications 
         meningitis 
         brain abscess/cerebritis          
16/30 (53,3%) 
 
11/16 (68,7%) 
0 
 
4/16 (25%) 
1/16 (6,2%) 
10 (83,3%) 
 
6 
0 
 
4 
0 
6 (33,3%) 
 
5 
0 
 
0 
1 
0,020 
 
 
N/A 
     
systemic embolization 10 (33,3%) 7 (58,3%) 3 (16,6%) 0,045 
mortality                                   23,3% (7/30) 33,3% (4/12) 16,6% (3/18) 0,391 
 
Legend: 
*MES = microembolic signal 
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Table 2 . Characteristics of sixteen patients with native valve IE and neurological  
   complications 
 
 
 
 
No. 
 
 
etiology 
 
 
affected 
valve 
 
 
MES* 
 
(Yes/No) 
 
TCD♦ timing 
(duration of 
disease/treatment) 
- days 
onset of 
neurological 
complication 
regarding to 
TCD♦ study - 
days 
 
 
neurological 
complication 
 
 
valve 
surgery 
(yes/no) 
 
 
outcome 
1 
 
 
Str.intermedius AML Yes 13/7 2 meningitis No alive 
2 
 
 
S. aureus MV Yes 14/14 3 ischemic 
stroke 
No alive 
3 
 
 
S. aureus AML No 3/2 3 ischemic 
stroke 
No death 
4 
 
 
S. aureus PML Yes 6/3 1 meningitis No alive 
5 
 
 
S. aureus AV Yes 2/1 2 meningitis No death 
6 
 
 
S. aureus AML 
and AV 
Yes 10/3 7 ischemic 
stroke 
No death 
7 
 
 
S. aureus AV Yes 10/2 1 meningitis Yes alive 
8 
 
 
MRSA AML Yes 7/7 1 ischemic 
stroke 
No death 
9 
 
 
MRSA AML Yes 9/2 2 ischemic 
stroke 
Yes alive 
10 
 
 
Moraxella 
lacunata 
PML No 13/3 5 cerebritis Yes alive 
11 
 
 
Enterococcus 
faecalis 
AV No 14/5 18 ischemic 
stroke 
No alive 
12 
 
 
Str. agalactiae AV Yes 11/5 2 ischemic 
stroke 
No alive 
13 
 
 
Str. agalactiae AML Yes 4/2 2 ischemic 
stroke 
No alive 
14 
 
 
UKN AV No 14/7 6 ischemic 
stroke 
No alive 
15 
 
 
UKN AML No 10/4 1 ischemic 
stroke 
Yes alive 
16 
 
 
UKN AV No 12/5 7 ischemic 
stroke 
No death 
 
Legend: 
 
AV - aortic valve 
MV - mitral valve 
AML - anterior mitral leaflet 
PML - posterior mitral leaflet 
MES - microembolic signals 
UKN - unknown 
*MES = microembolic signal 
♦TCD= Transcranial Doppler ultrasound 
 
